Clinical
Trials
- A Study of Zanubrutinib Versus Ibrutinib in Patients With Relapsed/Refractory Chronic Lymphocytic LeukemiaCondition:Leukemia, LymphomaMolecule:Zanubrutinib
- A Phase 1b Study to Assess Sitravatinib in Combination With Tislelizumab in Patients With Advanced Solid TumorsCondition:Advanced solid tumorsMolecule:Sitravatinib + Tislelizumab
- Study of BGB-A425 in Combination With Tislelizumab in Advanced Solid TumorsCondition:Advanced solid tumorsMolecule:BGB-425 + Tislelizumab
- Study of BGB-A333 Alone and in Combination With Tislelizumab in Advanced Solid TumorsCondition:Advanced solid tumorsMolecule:BGB-A333 + Tislelizumab
- Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer With Homologous Recombination DeficiencyCondition:Prostate CancerMolecule:Pamiparib
- A Study Evaluating the Efficacy and Safety of Tislelizumab Versus Chemotherapy in Advanced Non-Squamous NSCLCCondition:Lung CancerMolecule:Tislelizumab
- A Study of Tislelizumab in Combination With Chemotherapy Versus Chemotherapy in Advanced Lung CancerCondition:Lung CancerMolecule:Tislelizumab
- A Study of Tislelizumab Versus Chemotherapy as First Line Treatment in Patients With Advanced Esophageal Squamous Cell Carcinoma (ESCC)Condition:Esophageal CancerMolecule:Tislelizumab
- Tislelizumab in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Gastric, or Gastroesophageal Junction CarcinomaCondition:Gastric Cancer, Esophageal CancerMolecule:Tislelizumab
- Tislelizumab in MSI-H or dMMR Solid TumorsCondition:Advanced solid tumorsMolecule:Tislelizumab
See All Trials
Clinical trials are an important part of our research and development efforts and help make possible access to safe and potentially life-saving treatments.